Ledger.Open graph →
SEC Form D · filed June 25, 2020

REATA PHARMACEUTICALS INC

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PLANO, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

J. K. Mcgaughy, Jr · Plano, TXDirectorJ. W. Huff · Plano, TXExec · DirectorMichael D. Wortley · Plano, TXExecManmeet S. Soni · Plano, TXExecColin J. Meyer, M.D · Plano, TXExecWilliam D. Mcclellan, Jr · Plano, TXDirectorJack B. Nielsen · 3584 CM Utrecht, P7DirectorDawn C. Bir · Plano, TXExecJames E. Bass · Plano, TXDirectorWilliam E. Rose · Plano, TXDirectorMichael D. Wortley · Plano, TXExecManmeet S. Soni · Plano, TXExecColin J. Meyer, M.D · Plano, TXExecWilliam D. Mcclellan, Jr · Plano, TXDirectorJ. K. Mcgaughy, Jr · Plano, TXDirectorJack B. Nielsen · 3584 CM Utrecht, P7DirectorDawn C. Bir · Plano, TXExecJames E. Bass · Plano, TXDirectorWilliam E. Rose · Plano, TXDirectorJ. W. Huff · Plano, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗